[HTML][HTML] Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities
SS Hu, Z Batool, X Zheng, Y Yang, A Ullah… - Journal of …, 2024 - Elsevier
Protozoan infections (eg, malaria, trypanosomiasis, and toxoplasmosis) pose a considerable
global burden on public health and socioeconomic problems, leading to high rates of …
global burden on public health and socioeconomic problems, leading to high rates of …
A Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery
Over the past few decades, advancements in nanocarrier-based therapeutic delivery have
been significant, and niosomes research has recently received much interest. The self …
been significant, and niosomes research has recently received much interest. The self …
Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model
AA Abdel-Wahab, DA Shafey, SM Selim, SA Sharaf… - Parasitology …, 2024 - Springer
Despite being the initial choice for treating toxoplasmosis, sulfadiazine and pyrimethamine
have limited effectiveness in eliminating the infection and were linked to a variety of adverse …
have limited effectiveness in eliminating the infection and were linked to a variety of adverse …
Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Ameliorate Murine Chronic Toxoplasmosis
Toxoplasma gondii causes a global parasitic disease. Therapeutic options for eradicating
toxoplasmosis are limited. In this study, ZnO and Mg-doped ZnO NPs were prepared, and …
toxoplasmosis are limited. In this study, ZnO and Mg-doped ZnO NPs were prepared, and …
Effect of Platelet Rich Plasma versus Conventional Therapy on Early and Late ME 49 Toxoplasma Gondii Infection in Immunocompromised Mice
AM Mahgoub, NZ Yassa, SH El-Sayed… - Egyptian Journal of …, 2024 - ejvs.journals.ekb.eg
Toxoplasmosis is a highly prevalent worldwide opportunistic parasitic infection caused by
Toxoplasma gondii. It is associated with various morbidities in immunocompetent patients …
Toxoplasma gondii. It is associated with various morbidities in immunocompetent patients …
[引用][C] Evaluación del antígeno excretor/secretor y de membrana de Toxoplasma gondii para la detección de la infección en pacientes en fase aguda mediante …
JLP ESPINOZA - 2024 - Universidad Nacional Mayor de San …